Published: 2018-11-22

Study of HbA1C levels in patients with type 2 diabetes mellitus in relation to diabetic retinopathy in Indian population

Lokesh S., Shivaswamy S.


Background: In the recent years diabetes mellitus (DM) has emerged as a major public health problem worldwide with potential to develop vascular and neuropathic complications. HbA1c has got an important role in monitoring the treatment and risk of developing micro and macrovascular complications. Present study is done to determine the prevalence of diabetic retinopathy (DR) in association with raise in HbA1c and also to correlate the severity of Diabetic retinopathy with the levels of HbA1c.

Methods: In this descriptive observational study 50 diabetes mellitus patients with visual disturbances who attended the Department of General medicine and Department of Ophthalmology between January 2012 to December 2012 at Vydehi institute of medical sciences and research centre are selected. All the patients were subjected to the relevant investigations along with dilated retinal examination and slit lamp examination. The results were tabulated according to the severity of retinopathy and other clinical variables.

Results: In this study majority of the patient were in the age group of 61-70 years and 68% were male patients. Mean duration of diabetes mellitus was 9.8±5.34 years. Also 54% of them had coexisting hypertension. Present study showed the presence of diabetic retinopathy in 64% of patients, out of which 24% of them had mild DR and 14% had moderate DR.

Conclusions: Present study showed as the HbA1c level increases severity of the diabetic retinopathy also increases. And also, patients who had microalbuminuria and longer the duration of diabetes higher the chances of microvascular complications. Hence HbA1c can be used as a useful tool to assess the long-term control of diabetes mellitus and hence the development of diabetic retinopathy.


Diabetes mellitus, Macular edema, Retinopathy

Full Text:



International diabetic federation. IDF Diabetes Atlas. 7th ed. Brussels: International Diabetic federation, 2015. Available at: http:/ html.

Andrew farmer. Monitoring Diabetes In:Holt RIG, Cockram CS, Flyvbjerg Goldstein BJ, eds. Text book of Diabetes.5th ed. Wiley Blackwell;2017:374-384.

Pirate J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabete Metab. 1977 Dec;3(4):245-56.

Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care. 1995 Feb;18(2):258-68.

Toke Bek. Diabetic Retinopathy In:Holt RG, Cockram CS, Flyvbjerg Goldstein BJ, eds. Text book of Diabetes. 5th ed. Wiley Blackwell;2017: 554-565.

Mitchell P, Smith W, Wang JJ, Attebo K. Prevalence of diabetic retinopathy in an older community: the Blue Mountains Eye Study. Ophthalmol. 1998 Mar 1;105(3):406-11.

Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984 Apr 1;102(4):527-32.

Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I. Investigative Ophthalmol Visual Sci. 2005 Jul 1;46(7):2328-33.

Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England J Med. 1993 Sep 30;329(14):977-86.

UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998 Sep 12;352(9131):837-53.

Leske MC, Wu SY, Hennis A, Hyman L, Nemesure B, Yang L, et al, Barbados Eye Study Group. Hyperglycemia, blood pressure, and the 9-year incidence of diabetic retinopathy: the Barbados Eye Studies. Ophthalmol. 2005 May 1;112(5):799-805.

McKay R, McCarty CA, Taylor HR. Diabetic retinopathy in Victoria, Australia: the visual impairment project. Br J Ophthalmol. 2000 Aug 1;84(8):865-70.

West SK, Klein R, Rodriguez J, Muñoz B, Broman AT, Sanchez R, et al. Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER. Diabetes Care. 2001 Jul 1;24(7):1204-9.

Niveditha H, Yogitha C, Liji P, Sundeep S, Himamshu NV, Vinutha BV, et al. Clinical correlation of HbA1c and diabetic nephropathy with diabetic retinopathy. J Evolution Med Dental Sci. 2013 Dec 9;2(49):9430-6.

Gadkari SS, Maskati QB, Nayak BK. Prevalence of diabetic retinopathy in India: The all India ophthalmological society diabetic retinopathy eye screening study 2014. Indian J Ophthalmol. 2016 Jan;64(1):38.

Manaviat MR, Afkhami M, Shoja MR. Retinopathy and microalbuminuria in type II diabetic patients. BMC Ophthalmol. 2004 Dec;4(1):9.

Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature. Arch Internal Med. 1997 Jul 14;157(13):1413-8.